Suven Pharmaceuticals Ltd. (COHANCE) Cash flow

2 Followers

Suven Pharmaceuticals Ltd. Cash Flow

IN:COHANCE's free cash flow for Q2 2026 was ₹1.71B. For the 2026 fiscal year, IN:COHANCE's free cash flow was decreased by ₹-1.74B and operating cash flow was ₹2.61B. See a summary of the company’s cash flow.

Cash Flow	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Operating Cash Flow	₹ 2.88B	₹ 3.58B	₹ 4.51B	₹ 3.30B	₹ 3.83B
Investing Cash Flow	₹ -2.55B	₹ -3.62B	₹ -1.95B	₹ -1.36B	₹ -3.11B
Financing Cash Flow	₹ 33.20M	₹ -138.02M	₹ -2.36B	₹ -1.56B	₹ -765.53M
End Cash Position	₹ 856.00M	₹ 472.31M	₹ 648.03M	₹ 445.64M	₹ 71.82M
Free Cash Flow	₹ 1.32B	₹ 3.07B	₹ 1.65B	₹ 2.55B	₹ 2.73B

Currency in INR